Professor Richard Aspinall

Tuesday, October 31 2017 at 7:30PM

Download iCalendar file
(e.g. import to Outlook or Google Calendar)


2 Norfolk Street

Professor Richard Aspinall

What's the talk about?

Tickets: £3.00 advance / £4.00 on the door
Box Office:

Immortality has held us fascinated throughout history and there are many examples of individuals searching for the elixer of life or the fountain of youth because they wished to live forever. There are even some reports that some like the Comte de St Germain have succeeded.

More recently the goals have been modified or even shifted slightly with reports that rather than being immortal we will soon be able to live to be 1000 years old, that’s if we start treating the body like a machine and replacing those bits that wear out with time. 

All of this seems to some to be plausible and the problems seem to be associated with how do we cope with overcrowding or how do we pay for the treatments. This skips over the first problem which is when do we make the decision to adopt any therapies directed at lifespan extension? At what age do we decide that we wish to maintain ourselves and live forever or at least a thousand years? 
As a sceptic I would propose that we give up all hope for immortality and eternal youth and accept out fate and our allotted span, but making the best of what we have been given. 
Richard is a recognised expert in the area of age associated immune deficiencies and issues concerning vaccination in older people. He has degrees from Bristol University, Birmingham University and Cranfield University. He has worked at Oxford University, the Babraham Institute, Imperial College, Cranfield University and a biotech company. He is a member of the British Society for Immunology and the British Society for Research on Ageing. 
In addition he is section editor for Immunity and Ageing and also Experimental Gerontology. He has been a Member of MRC College of Experts, Chairman of the British Society for Research on Ageing, and a consultant for several major pharmaceutical companies. He was appointed a Fellow of the Higher Education Academy in 2007, a Fellow of the Royal College of Physicians (Edin) in 2012 and a Fellow of the Royal College of Pathology in 2014. In 2015 he was awarded the Lord Cohen Medal for his contribution to ageing research.